Penn Medicine surgeons perform world’s first robotic breast reconstruction Photo courtesy: Rebecca Elias Abboud for Penn Medicine Penn Medicine surgeons perform world’s first robotic breast reconstruction A team of surgeons from the Perelman School of Medicine are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction, allowing for a minimally invasive procedure that enhances recovery and eliminates narcotics.
Workplace pumping made easier Dare Henry-Moss, an adjunct fellow at the Center for Public Health Initiatives, developed a recommendation plan for improving lactation support for the University of Pennsylvania Health System, including conducting a needs assessment intended to guide standards for such spaces. Workplace pumping made easier Listening to employee feedback, Penn Medicine added hospital-grade pumps and doubled its lactation spaces, taking strides to help women meet their breastfeeding goals.
Treating spinal pain with ‘engineered living tissue’ moves closer to reality Treating spinal pain with ‘engineered living tissue’ moves closer to reality A multidisciplinary team at Penn successfully demonstrated the feasibility of an innovative new disc replacement made of living material.
Why we have hair here, but not there Why we have hair here, but not there A new study answers a fundamental question in human evolution about how and where hair grows on the body, and reveals the existence of a naturally-occurring inhibitor to hair growth.
World AIDS Day: What’s happening with the epidemic today The SERO Project, one of six community organizations featured in this year’s Day With(out) Art program at the Institute of Contemporary Art, is pictured at a workshop event earlier this year. The group advocates for people living with HIV and fights laws that criminalize sexual partners for non-disclosure of HIV status. (Photo courtesy: The Institute of Contemporary Art.) Q&A World AIDS Day: What’s happening with the epidemic today Professor of Medicine and Associate Chief of the Infectious Diseases Division Ian Frank explains progress made and challenges still faced in the world of HIV/AIDS research, prevention, and treatment.
FDA approves new targeted drug for leukemia FDA approves new targeted drug for leukemia The drug is the first to target common mutations associated with relapse and short survival in acute myeloid leukemia.
A link between anti-malaria drugs and cancer treatments, explained A link between anti-malaria drugs and cancer treatments, explained The Abramson Cancer Center study is the first to identify what drugs known as chloroquines are targeting when used for cancer treatment.
Modeling the most common form of vision loss in older adults As the population ages, cases of age-related macular degeneration are forecast to skyrocket. New research led by a team from Penn may help make inroads into understanding its roots and possible therapies. Modeling the most common form of vision loss in older adults Age-related macular degeneration is the leading cause of vision loss in people older than 50. Kathleen Boesze-Battaglia and colleagues have developed a model system that mimics many features of the human condition, giving scientists a platform to gain a deeper understanding of risk factors and possible treatments.
The Power of Penn in London Penn President Amy Gutmann (left) was joined by (from left to right) faculty members Henry Daniell, Kathleen Morrison, and Anjan Chatterjee at the Nov. 15 Power of Penn event in London. The Power of Penn in London In London, President Amy Gutmann presented the vision for the University’s $4.1 billion campaign, The Power of Penn.
Racial disparities in sudden cardiac death rates cannot be explained by known risk factors Racial disparities in sudden cardiac death rates cannot be explained by known risk factors Despite controlling for factors including income, smoking, and cholesterol levels, black patients remain at high risk.